Vanguard Fiduciary Trust’s Cocrystal Pharma COCP Stock Holding History

Vanguard Fiduciary Trust’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.2K	Hold	24,016	–	–	﹤0.01%	3966
2026 Q1	$24.3K	Buy	+24,016	New	+$24.8K	﹤0.01%	3927

Other funds holding COCP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Fiduciary Trust's COCP Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Cocrystal Pharma (COCP) position steady in Q2 2026 at 24,016 shares worth $25.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3966.

Vanguard Fiduciary Trust first reported a position in COCP in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

Vanguard Fiduciary Trust held 24,016 shares of Cocrystal Pharma worth $25.2K as of Q2 2026.
Vanguard Fiduciary Trust left its Cocrystal Pharma share count unchanged in Q2 2026.
Cocrystal Pharma made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3966 holding.
Vanguard Fiduciary Trust first reported a position in Cocrystal Pharma in Q1 2026 and has held it in 2 quarters since.
27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.